BRUNO, ELVIRA
 Distribuzione geografica
Continente #
EU - Europa 394
NA - Nord America 224
AS - Asia 50
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 670
Nazione #
US - Stati Uniti d'America 224
PL - Polonia 186
IT - Italia 77
IE - Irlanda 61
CN - Cina 40
SE - Svezia 39
BE - Belgio 13
IN - India 8
FI - Finlandia 7
DE - Germania 4
GB - Regno Unito 3
VN - Vietnam 2
AT - Austria 1
CL - Cile 1
EU - Europa 1
FR - Francia 1
RO - Romania 1
UA - Ucraina 1
Totale 670
Città #
Warsaw 186
Dublin 61
Messina 50
Chandler 39
Ann Arbor 36
Nyköping 34
Beijing 18
Ashburn 17
Brussels 13
Dearborn 10
Jacksonville 8
Princeton 8
Cambridge 7
Medford 5
Bielefeld 4
Boardman 4
Cagliari 4
Des Moines 4
Hyderabad 4
Jinan 4
Nanjing 4
San Mateo 4
Wilmington 4
Catania 3
Woodbridge 3
Delhi 2
Dong Ket 2
Hebei 2
Houston 2
Jiaxing 2
Milan 2
New York 2
Ningbo 2
Pune 2
Seattle 2
Aci Sant'antonio 1
Bordeaux 1
Dundee 1
Francofonte 1
Haikou 1
Hangzhou 1
Nanchang 1
Palermo 1
Qingdao 1
Shenyang 1
Taiyuan 1
Vienna 1
Zhengzhou 1
Totale 567
Nome #
Probing the molecular interactions between human Carbonic Anhydrases (hCAs) and a novel class of designed benzenesulfonamides 343
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 77
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 67
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 64
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 56
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 49
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 46
Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2 6
Totale 708
Categoria #
all - tutte 1.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 9 2
2019/202092 0 3 4 2 5 19 8 8 7 21 10 5
2020/2021100 4 7 13 3 12 4 17 3 7 25 1 4
2021/202272 1 11 1 6 1 1 7 5 1 2 22 14
2022/2023165 11 11 10 16 10 13 3 8 81 0 0 2
2023/202450 6 6 3 13 3 9 0 5 0 5 0 0
Totale 708